EUVIMEDEUVIMED entdecken
Crossref

The Role of Serial Serum Carbohydrate Antigen 19‐9 Surveillance to Detect Recurrences after Curative Resection for Gallbladder Carcinoma

Afroj Ismail Bagwan iD, Gurudutt Varty, Shraddha Patkar iD, Balappagouda Patil, Faisal Abdul Mujeeb, Mizelle D'Silva iD, Vikas Ostwal iD, Anant Ramaswamy iD, Goel Mahesh iD

Journal of Surgical Oncology · 2026-11 · 134 (6) · 870-878

DOI: 10.1002/jso.70357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 10.08.2026. Verfasst von Afroj Ismail Bagwan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, CA-19-9 Antigen, Neoplasm Recurrence, Local, Biomarkers, Tumor. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gallbladder cancer (GBC) is the most common biliary tract malignancy with aggressive biology and poor outcomes. Early detection of recurrence after curative resection is crucial to enable timely systemic therapy. This study evaluates role of Carbohydrate Antigen 19‐9 (CA 19‐9) surveillance in detecting recurrence after radical surgery for GBC. Material and Methods Retrospective analysis of a prospectively maintained database was conducted at Tata Memorial Hospital, India, between 2010 and 2024. Patients undergoing curative‐intent resection for GBC were included. Postoperative CA 19‐9 trends, including first elevated value and serial rise were analyzed to detect recurrence.

Results

A total of 813 patients were analyzed; 327 (40.2%) developed recurrence. Among them, 210 (64.2%) had a postoperative CA19‐9 rise. Fifty‐three patients had CA 19‐9 elevation without clinico‐radiological recurrence. A first raised CA 19‐9 value (> 37 U/mL) predicted recurrence with 64.5% sensitivity, 89.3% specificity (AUC = 0.681). A serial rise in CA 19‐9 value yielded 45.6% sensitivity and 95.3% specificity. The median duration between first raised CA 19‐9 value and radiological detection of recurrence was 5.4 weeks.

Conclusions

Serum CA 19‐9 surveillance detects early recurrences in resected GBCs with modest sensitivity and specificity. Serial rise in CA 19‐9 should prompt more detailed investigations to detect recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallbladder NeoplasmsCA-19-9 AntigenNeoplasm Recurrence, LocalBiomarkers, TumorHumansRetrospective StudiesFemaleMiddle AgedMaleAgedFollow-Up Studies

Stichwörter der Autor:innen

cancer recurrencegallbladder carcinoma (GBC)post‐operative surveillanceserum CA 19‐9tumor biomarkers

Substanzen

CA-19-9 AntigenBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.

ORCID-Profile: Afroj Ismail Bagwan, Shraddha Patkar, Mizelle D'Silva, Vikas Ostwal, Anant Ramaswamy, Goel Mahesh

Zitieren

APA

Bagwan, A. I., Varty, G., Patkar, S., Patil, B., Mujeeb, F. A., D'Silva, M., Ostwal, V., Ramaswamy, A., & Mahesh, G. (2026). The Role of Serial Serum Carbohydrate Antigen 19‐9 Surveillance to Detect Recurrences after Curative Resection for Gallbladder Carcinoma. Journal of Surgical Oncology, 134(6), 870-878. https://doi.org/10.1002/jso.70357

Vancouver

Bagwan AI, Varty G, Patkar S, Patil B, Mujeeb FA, D'Silva M, et al. The Role of Serial Serum Carbohydrate Antigen 19‐9 Surveillance to Detect Recurrences after Curative Resection for Gallbladder Carcinoma. Journal of Surgical Oncology. 2026;134(6):870-878. doi:10.1002/jso.70357

BibTeX
@article{Bagwan2026,
  author = {Bagwan, Afroj Ismail and Varty, Gurudutt and Patkar, Shraddha and Patil, Balappagouda and Mujeeb, Faisal Abdul and D'Silva, Mizelle and Ostwal, Vikas and Ramaswamy, Anant and Mahesh, Goel},
  title = {The Role of Serial Serum Carbohydrate Antigen 19‐9 Surveillance to Detect Recurrences after Curative Resection for Gallbladder Carcinoma},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  volume = {134},
  number = {6},
  pages = {870--878},
  doi = {10.1002/jso.70357}
}
Kostenlos starten →